Original BioMedicals Co., Ltd. (TPEX:6483)

Market Cap	881.87M +2.2%
Revenue (ttm)	n/a
Net Income	-102.24M
EPS	-1.53
Shares Out	66.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,016
Open	13.25
Previous Close	13.20
Day's Range	12.90 - 13.35
52-Week Range	9.12 - 20.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Original BioMedicals

Original BioMedicals Co., Ltd. engages in the development of drugs in Taiwan. The company develops OBM-A01, a radiation injury prevention and therapeutic drug for the treatment of acute radiation injuries, including nuclear radiation and solar radiation exposure in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; CCM-CL, a cyclic polypeptide antibiotic; and Iron Dextran, an injection for the treatment of iron deficiency. It also provides NE (vitamin C+E) and NE Butorphanol, as well as technical services. Or...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Employees: 25
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6483

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 8, 2026

Data Sources Report a data error